Respiratory System Agents
"Respiratory System Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used for their effects on the respiratory system.
| Descriptor ID |
D019141
|
| MeSH Number(s) |
D27.505.954.796
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Respiratory System Agents".
Below are MeSH descriptors whose meaning is more specific than "Respiratory System Agents".
This graph shows the total number of publications written about "Respiratory System Agents" by people in this website by year, and whether "Respiratory System Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Respiratory System Agents" by people in Profiles.
-
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial. Chest. 2021 03; 159(3):985-995.
-
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. Lancet Respir Med. 2018 10; 6(10):747-758.
-
Novel Aerosol Delivery Devices. Semin Respir Crit Care Med. 2015 Aug; 36(4):543-51.
-
Intensive symptom control of opioid-refractory dyspnea in congestive heart failure: Role of milrinone in the palliative care unit. Palliat Support Care. 2015 Dec; 13(6):1781-5.
-
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med. 2012 May 15; 185(10):1044-8.
-
Airway stenting for emphysema: back to the drawing board. Semin Thorac Cardiovasc Surg. 2011; 23(4):263-5.
-
Prediction of panic response to a respiratory stimulant by reduced orbitofrontal cerebral blood flow in panic disorder. Am J Psychiatry. 2005 Jul; 162(7):1379-81.